Cement good for next 2 years; top 2 bets in banks: Devang Mehta

Relative comfort on valuation is to be found in large caps in sectors such as BFSI, pharma and healthcare over a one-year horizon, says Vetri Subramaniam, CIO at UTI AMC.

Kaustubh Pawaskar, DVP, Fundamental Research at BNP Paribas, predicts that Q2 will be a weak quarter for consumer goods companies, with no significant improvement in demand. However, higher margins may contribute to decent bottom line growth. Pawaskar expects a recovery in volumes from Q3, driven by stable urban consumption and increased government spending in rural markets. The QSR space has been impacted by inflationary pressures, but burgers and sandwiches will perform well from Q3.

Mahantesh Sabarad says: “A mixture of events that has caused this underperformance on HDFC Bank overall. And within that mixture one cannot wish away what is happening to the banking sector per se. The banking sector is now on a high in terms of credit growth. The YoY credit growth number is upwards of 16% thereabouts.”

Nimesh Chandan, CIO of Bajaj Finserv Asset Management, believes that the markets have reached fair and higher than reasonable valuations. A change in approach is necessary, and investors should look for bargains in undervalued areas. The paint industry is experiencing an influx of new players, which may impact existing players' market share and valuations.

From the valuation parameter, the price to earnings ratio has gone from 24 to 19 times. In price to book, we are below the 10-year average. If you look at the earnings yield, it is roughly about 5.6%. If you look at market cap GDP, we are at 94%. The peak was about 112%. In the last 18 months, the total economic growth, the GDP growth is 20%. For Nifty, it is minus 9%.

Sushant Bhansali of Ambit Asset Management believes that the equity market rally in India is going to continue due to a broad-based market and positive changes in smallcaps. He expects margin expansion to reverse but with good sales growth. He sees opportunities in discretionary spending and expects competition in the paint industry to expand the market.

Banking, NBFCs, and MFIs are good places to invest as the Indian banking sector has cleaned up its books, making credit growth pick up significantly. Capital goods and power sector are well-poised for growth in the next 2-3 years with high government investment in railways, highways, and airports. Companies in the capital goods sector, despite some trading at high price-to-earnings ratios, are expected to contract PEs due to anticipated high growth in the next few quarters. Additionally, the pharma sector is expected to show strong earnings growth in the next 2-3 years.

Nilesh Shah anticipates largecap IT decline, supports specialised technology services growth. He believes online consumer or the online fintech space are the businesses which are making rapid strides. While acknowledging market froth, advises against tactical allocations. shifting funds from small and midcaps to largecaps Further, Shah emphasizes bottom-up opportunities, energy sector potential, and regulatory risks in the insurance sector.

Sandeep Raina is not worried about the market crash. Further small cuts are possible, but it's not a bloodbath. Stay invested, the market will revive. Quality midcaps, smallcaps, and largecaps with 20% growth, good ROCE, and cash flows are worth investing. Pharma stocks like Beta Drugs, Kilpest, and Sun Pharma are interesting.

​In my viewpoint, since they are heavyweights on the index and they represent the indices, of course, so in such situation when they start going up because of the higher amount of money coming into the system as well I would think that indices would naturally go up.